Registered Plan Private Investments (Registered Plan Private Investments) Other Long-Term Liabilities : $0.00 Mil (As of Dec. 2019)

View and export this data going back to 2017. Start your Free Trial

What is Registered Plan Private Investments Other Long-Term Liabilities?

Registered Plan Private Investments's other long-term liabilities for the quarter that ended in Dec. 2019 was $0.00 Mil.

Registered Plan Private Investments's quarterly other long-term liabilities increased from Jun. 2019 ($0.00 Mil) to Sep. 2019 ($0.00 Mil) but then declined from Sep. 2019 ($0.00 Mil) to Dec. 2019 ($0.00 Mil).

Registered Plan Private Investments Other Long-Term Liabilities Historical Data

The historical data trend for Registered Plan Private Investments's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Registered Plan Private Investments Other Long-Term Liabilities Chart

Registered Plan Private Investments Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Other Long-Term Liabilities

Registered Plan Private Investments Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Other Long-Term Liabilities	Get a 7-Day Free Trial											-	-	-	-	-

Registered Plan Private Investments Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Registered Plan Private Investments Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Registered Plan Private Investments's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Registered Plan Private Investments (Registered Plan Private Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Registered Plan Private Investments Inc (OTCPK:LXGTF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Hastings Street, Suite 1900, Vancouver, BC, CAN, V6E 2E9

Website

https://lexingtonbiosciences.com

Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.

Registered Plan Private Investments (Registered Plan Private Investments) Headlines

From GuruFocus

Lexington Provides Q3 Corporate Review

By Marketwired Marketwired • 10-24-2018

Lexington Biosciences Announces Termination of Private Placement

By Marketwired Marketwired • 02-15-2019

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

By Marketwired Marketwired • 07-25-2018

Lexington Biosciences Announces Results of Annual General Meeting

By Marketwired Marketwired • 07-03-2018

Lexington Biosciences Provides Update on Financial Situation

By Marketwired Marketwired • 04-02-2019

Lexington Releases Audited Consolidated Financial Statements

By Marketwired Marketwired • 05-01-2018

Lexington Announces First Multicenter Clinical Study Site

By Marketwired Marketwired • 08-21-2018

Lexington Engages with Major Canadian University and Provides Clinical Trial Update

By Marketwired Marketwired • 05-08-2018